At a glance
- Originator Nippon Zoki
- Class Antihyperglycaemics; Pyrimidinones; Small molecules; Thiazoles
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic complications